Facetten
Zugriff
Einrichtung
Medientyp
- Text 49
Karte
Erscheinungsjahr
Autor/in
- Haferlach, Claudia
- Bacher, Ulrike 43
- Schnittger, Susanne 39
- Haferlach, Torsten 38
- Kern, Wolfgang 35
- alle zeigen
Sprache
49 Einträge gefunden
-
-
-
Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes
- Ganster, Christina
- Müller-Thomas, Catharina
- Haferlach, Claudia
- Strupp, Corinna
- Ogata, Kiyoyuki
- Germing, Ulrich
- Hildebrandt, Barbara
-
Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy
- Haaß, Wiltrud
- Kleiner, Helga
- Weiß, Christel
- Haferlach, Claudia
- Schlegelberger, Brigitte
- Müller, Martin C
- Hehlmann, Rüdiger
-
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV
- Hehlmann, Rüdiger
- Müller, Martin C
- Lauseker, Michael
- Hanfstein, Benjamin
- Fabarius, Alice
- Schreiber, Annette
- Proetel, Ulrike
-
-
-
-
-
Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.
- Bacher, Ulrike
- Schnittger, Susanne
- Macijewski, Katja
- Grossmann, Vera
- Kohlmann, Alexander
- Alpermann, Tamara
- Kowarsch, Andreas
-
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.
- Schnittger, Susanne
- Bacher, Ulrike
- Eder, Christiane
- Dicker, Frank
- Alpermann, Tamara
- Grossmann, Vera
- Kohlmann, Alexander
-
TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
- Bacher, Ulrike
- Weissmann, Sandra
- Kohlmann, Alexander
- Schindela, Sonja
- Alpermann, Tamara
- Schnittger, Susanne
- Kern, Wolfgang
-
-
-
-
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.
- Hehlmann, Rüdiger
- Lauseker, Michael
- Jung-Munkwitz, Susanne
- Leitner, Armin
- Müller, Martin C
- Pletsch, Nadine
- Proetel, Ulrike
-
-
CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.
- Haferlach, Claudia
- Bacher, Ulrike
- Kohlmann, Alexander
- Schindela, Sonja
- Alpermann, Tamara
- Kern, Wolfgang
- Schnittger, Susanne
-
Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms.
- Bacher, Ulrike
- Haferlach, Torsten
- Alpermann, Tamara
- Kern, Wolfgang
- Schnittger, Susanne
- Haferlach, Claudia
-
A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.
- Schnittger, Susanne
- Bacher, Ulrike
- Eder, Christiane
- Lohse, Peter
- Haferlach, Claudia
- Kern, Wolfgang
- Haferlach, Torsten